- Home
- MRT vs HRTX Comparison
MRT vs HRTX Comparison
Compare MRT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRT
- HRTX
- Stock Information
- Founded
- MRT 2018
- HRTX 1983
- Country
- MRT Turkey
- HRTX United States
- Employees
- MRT N/A
- HRTX N/A
- Industry
- MRT Rental/Leasing Companies
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRT Consumer Discretionary
- HRTX Health Care
- Exchange
- MRT Nasdaq
- HRTX Nasdaq
- Market Cap
- MRT 228.0M
- HRTX 242.0M
- IPO Year
- MRT N/A
- HRTX 1987
- Fundamental
- Price
- MRT $2.29
- HRTX $1.32
- Analyst Decision
- MRT Strong Buy
- HRTX Strong Buy
- Analyst Count
- MRT 2
- HRTX 2
- Target Price
- MRT $6.00
- HRTX $4.50
- AVG Volume (30 Days)
- MRT 188.1K
- HRTX 1.7M
- Earning Date
- MRT 01-01-0001
- HRTX 11-11-2025
- Dividend Yield
- MRT N/A
- HRTX N/A
- EPS Growth
- MRT N/A
- HRTX N/A
- EPS
- MRT N/A
- HRTX N/A
- Revenue
- MRT $24,577,378.00
- HRTX $149,694,000.00
- Revenue This Year
- MRT $84.11
- HRTX $10.62
- Revenue Next Year
- MRT $125.86
- HRTX $12.99
- P/E Ratio
- MRT N/A
- HRTX N/A
- Revenue Growth
- MRT 29.67
- HRTX 9.78
- 52 Week Low
- MRT $1.81
- HRTX $1.04
- 52 Week High
- MRT $3.89
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- MRT 46.38
- HRTX 48.46
- Support Level
- MRT $2.16
- HRTX $1.28
- Resistance Level
- MRT $2.46
- HRTX $1.39
- Average True Range (ATR)
- MRT 0.15
- HRTX 0.06
- MACD
- MRT 0.01
- HRTX 0.02
- Stochastic Oscillator
- MRT 64.00
- HRTX 63.41
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.